| November 14, 2013 | ISSUE NUMBER 325 VOL 11 |
Healthcare Reform
Health Reform May Boost Illicit Drug Sales
Health plans that limit drug converge will encourage consumers to obtain medicines illegally, according to pharmacy experts. Jill Wechsler reports ...Read more
Regulatory
Liability Looms for Generic Drug Safety Labeling Changes
FDA is proposing to revise its rules to permit generic drug manufacturers to initiate safety labeling changes, the aim of which is to inform consumers more quickly of emerging safety concerns. But it also could create confusion by allowing prescribing information to differ among generic and brand products ...Read more
Reimbursement
Make Room at the Drug Reimbursement Table for Patients and Researchers
“Reimbursement: Can Value Drive Innovation?” was one highlight of last week’s Partnering for Cures conference held in New York City. It looked at defining value and using models to engage payers early on with patients and researchers to achieve cost-savings and advances in medicine. Clark Herman reports. ...Read more
Scivigilance – Pharmacovigilance in a box
Technology and process enhancements play a crucial role in effective management of pharmacovigilance. Technology fosters collaboration between disparate teams, enables seamless flow of data, intuitive collection, processing and analysis of data. Cumulatively, effective combination of domain expertise, agile process and robust technology has allowed us to consistently demonstrate time savings, high quality, cost reductions, increased efficiency and absolute compliance.
The  whitepaper examines the use of scientific expertise, LEAN process and technology to deliver enhanced efficiency and compliance.
Special Feature
Pharm Exec’s 2014 Pipeline Report
This year's pipeline report takes a closer look at fewer categories – the ones where the biggest things are happening: cancer, heart failure, obesity and diabetes, and hepatitis C, in addition to novel antibiotics, not a goldmine by any stretch, but an absolutely critical need ...Read more
ZS Associates – Transforming Commercial Ops
 Watch this video to learn how pharma commercial operations leaders are creating efficient, effective organizations that operate as strategic resources within their companies.
Strategy
Get Real! Preparing for the Real-World-Evidence Future
Joakim Söderberg explains why real world evidence is here to stay, and what you need to do to integrate it into your business strategy as painlessly as possible ...Read more
New E-Book- Lifecycle Solutions: Positioning Pharmaceuticals For Commercial Success
Time is risk. If time to market is slowed then the cost for a company is lost revenues, profits, and ultimately lost opportunities for patients. The message is clear. To compete and win, companies must wrest more value from every stage of a new product’s tightly projected lifecycle. Download Now.
Pharmaceutical Executive editorial staff proudly introduces PharmExec TV, their latest high quality pertinent content in a brand new industry-breaking format. Tune In Now
Oncology Data Management Innovations
Live Webinar: Wednesday, November 20, 2013 at 1:00 pm EST
Register Free at  www.pharmexec.com/datamgmt
|
|
|
|
 //Celator Pharmaceuticals, Inc. (Ewing, NJ) announced the appointment of industry veteran Les Mintzmyer as Vice President, Manufacturing and Technical operations.//A.P. Pharma, Inc. (Redwood City, CA), appointed Paul Marshall as Senior Vice President of Technical Operations and Brian Drazba as Vice President of Finance and Chief Financial Officer.//Roche (Basel, Switzerland) appointed Susie Hackett as its first European Head of Communications. Ms Hackett was previously UK Director of Communications; she will remain based in the UK.//Canadian biotech company QLT Inc. announced that Vicente Anido, Jr. resigned from its Board of Directors.//The International Diabetes Federation (IDF) appointed Dr Petra Wilson as its new CEO.// |
|
|
|
|
|
 |
|
|
| |
|
|
 |
|
 |
Which area of pharma has the global recession impacted the most?
|
|
|
|
